105 results on '"Vassy R"'
Search Results
2. Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages
3. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells
4. 507 CCR1, SYNDECANS 1 AND 4, ARE INVOLVED IN RANTES/CCL5-MEDIATED MIGRATION OR INVASION OF HUMAN HEPATOMA CELLS
5. A001 Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets
6. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis
7. Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
8. Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice
9. Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative
10. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice
11. Rhenium-labelled antagonist to tuftsin receptor inhibits the VEGF binding to human endothelial cells
12. Nongenomic Effect of Triiodothyronine on Cell Surface -Adrenoceptors in Cultured Embryonic Cardiac Myocytes
13. Triiodothyronine and amiodarone effects on β3-adrenoceptor density and lipolytic response to the β3-adrenergic agonist BRL 37344 in rat white adipocytes
14. Antagonism between T3 and amiodarone on the contractility and the density of β-adrenoceptors of chicken cardiac myocytes
15. In vivo effects of macrolides on thyroid hormone serum levels and on hepatic type 1 5‘‐deiodinase in rat. A comparative study with amiodarone, phenobarbital and propranolol
16. Effects of troleandomycin and josamycin on thyroid hormone and steroid serum levels, liver function tests and microsomal monooxygenases in healthy volunteers: a double blind placebo‐controlled study
17. Amiodarone: influence of the route of administration on thyroid status and cardiac β‐adrenoceptors in the rat
18. Effect of a short term oral treatment by phenobarbital propranolol and amiodarone in rat on serum levels of fluorescent lipid-peroxidation products
19. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis [letter]
20. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice.
21. Effects of triiodothyonine administration on the adenylyl cyclase system in brown adipose of rat.
22. Triiodothyronine and amiodarone effects on β3-adrenoceptor density and lipolytic response to the β3-adrenergic agonist BRL 37344 in rat white adipocytes.
23. EFFECT OF NIFEDIPINE ON THYROTROPIN, PROLACTIN, AND THYROID HORMONE RELEASE IN MAN: A PLACEBO-CONTROLLED STUDY.
24. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
25. Amiodarone has exclusively non-genomic action on cardiac b-adrenoceptor regulation
26. Effect of a Somatostatin Analog (SMS 201-995) in Perfusion on Basal and Pentagastrin-Stimulated Calcitonin Levels in Medullary Thyroid Carcinoma.
27. Red cell ageing: phagocytosis and life-span of young and old erythrocytes fractionated by centrifugation
28. Desialosylation of mammalian and non mammalian red blood cells: Effect on in vivo survival in relation to the number of unmasked T-sites on VCN treated erythrocytes and serum T-agglutinin titers
29. Antagonism between T 3 and amiodarone on the contractility and the density of β-adrenoceptors of chicken cardiac myocytes
30. Cigarette-smoking, birthweight, thiocyanate and fluorescent lipid-peroxidation products in maternal and cord plasma
31. New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation.
32. Synthesis and evaluation of a tri-tyrosine decorated dextran MR contrast agent for vulnerable plaque detection.
33. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.
34. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
35. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
36. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets.
37. Distinct heparin binding sites on VEGF165 and its receptors revealed by their interaction with a non sulfated glycoaminoglycan (NaPaC).
38. A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis.
39. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.
40. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
41. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
42. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.
43. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
44. Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1.
45. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
46. Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.
47. In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1.
48. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).
49. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.
50. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.